scispace - formally typeset
K

Kalal Iravathy Goud

Researcher at Apollo Hospitals

Publications -  8
Citations -  81

Kalal Iravathy Goud is an academic researcher from Apollo Hospitals. The author has contributed to research in topics: Population & Cancer. The author has an hindex of 4, co-authored 8 publications receiving 69 citations.

Papers
More filters
Journal Article

Evaluation of HER-2/neu status in breast cancer specimens using immunohistochemistry (IHC) & fluorescence in-situ hybridization (FISH) assay

TL;DR: The results indicated that HER-2/neu status by FISH should be performed in all cases of breast tumour with a 2+ score by IHC, and there is also a need for establishing a clinically validated cut-off value for Her-2 /neu FISH amplification against IHC which may be further compared and calibrated.
Journal ArticleDOI

Sequence Variation of the Methylene Tetrahydrofolate Reductase Gene (677C>T and 1298 A>C) and Traditional Risk Factors in a South Indian Population

TL;DR: The results of this study indicate that the M THFR A1298C SNP is more prevalent among south Indians compared with the MTHFR C677T SNP, suggesting a possible role of MTH FR A 1298C in the pathogenesis of heart diseases.
Journal ArticleDOI

Molecular detection of Mycobacterium tuberculosis in pulmonary and extrapulmonary samples in a hospital-based study.

TL;DR: The results showed that RT-PCR should be implemented and given top priority in TB diagnosis to save time and facilitate a definitive diagnosis.
Journal ArticleDOI

Increasing role of cytogenetics in pediatric practice.

TL;DR: It is suggested that cytogenetic analysis is useful in the investigation of children with genetic disorders of unknown origin to confirm clinical diagnosis and to allow for proper genetic counseling.
Journal ArticleDOI

Positive Correlation Between Somatic Mutations in RAS Gene and Colorectal Cancer in Telangana Population: Hospital-Based Study in a Cosmopolitan City

TL;DR: Pyrosequencing, a reliable method for analyzing somatic mutations present in RAS, could aid in taking treatment decisions for patients with CRC.